Open-label, Crossover, Food Effect Study to Evaluate CT-044 in Healthy Human Volunteers
Status:
Completed
Trial end date:
2020-03-16
Target enrollment:
Participant gender:
Summary
This open-label study will be conducted to assess the bioavailability and PK of oral single
doses of CT-044 following administration with and without food and to evaluate the safety and
tolerability of CT-044 when given with and without food.